The new report by Expert Market Research titled, ‘Global Digital Breast Tomosynthesis Market Analysis, Size, Share, Trends, Growth, Report and Forecast 2021-2026’, gives in-depth analysis of the global digital breast tomosynthesis market, assessing the market based on its segments like product, applications and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/digital-breast-tomosynthesis-market/requestsample
The key highlights of the report include:
Market Overview (2016-2026): –
- Historical Market Size (2020): USD 2.43 Billion
- Forecast CAGR (2021-2026): 14%
The growing prevalence of breast cancer cases across the globe has driven the global digital breast tomosynthesis market. Growing public awareness of 2D and 3D mammography, well-developed treatment equipment, and technological developments in the approaches for the rapid diagnosis and identification of breast lesions all contribute to the market’s acceleration. Globally, rising healthcare expenditure and more knowledge about the benefits of DBT are also contributing to a considerable rise in the worldwide digital breast tomosynthesis market growth.
Industry Definition and Major Segments
Breast tomosynthesis, alternatively referred to as three-dimensional (3-D) mammography or digital breast tomosynthesis (DBT), is a more advanced kind of mammography that use a low-dose x-ray device and computer reconstructions to create three-dimensional images of the breasts. DBT is particularly beneficial for analyzing dense breasts and can aid the radiologist in detecting breast cancer.
The industry can be divided based on its application as:
- Diagnostic Centres
The industry can be classified based on its product type as:
- 2D/3D combination systems
- Standalone 3D systems
Based on region, the market is segmented into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Government attempts to raise awareness about breast cancer therapy, as well as an expanding patient population, are significant factors driving the global digital breast tomosynthesis (DBT) equipment market. Additionally, rising awareness among women regarding breast cancer detection and reduced radiation exposure procedures are likely to enhance the worldwide digital breast tomosynthesis (DBT) equipment market’s growth during the forecast period.
However, the high cost of equipment and maintenance is a significant issue impeding the market’s growth. Moreover, insufficient reimbursement regulations in certain countries and a shortage of skilled specialists are likely to restrain the global digital breast tomosynthesis (DBT) market growth. The DBT market has been segmented by product into 2D/3D combination systems and standalone 3D systems.
Globally increasing breast cancer prevalence and increased awareness of standalone DBT 3D systems as 2D mammograms have limitations owing to their precision, efficiency, and sensitivity, which are the primary factors driving the industry. By region, North America holds the largest share in the DBT market owing to highly developed healthcare systems and spending on healthcare.
According to US Breast Cancer Statistics, women in the United States are predicted to be diagnosed with an estimated 281,550 new cases of invasive breast cancer in 2021, as well as 49,290 new instances of non-invasive (in situ) breast cancer. The increasing number of cases is further fuelling the growth of the market.
The major players in the market are Hologic Inc. (HOLX: NASDAQ), Ge Healthcare, Siemens Healthineers (SHL: ETR), Dexela Ltd., and Fujifilm Corporation among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: EMR Inc.
Contact Person:-Ian Bell, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA